John McKnight

11.1k citations

137 papers · 4.9k indexed · 1 hit paper · h-index 40

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research 39
- Diabetes Treatment and Management 29
- Diabetes Management and Education 16
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Pituitary Gland Disorders and Treatments 9
Nephrology top 2%
Genetics top 2%
- Diabetes and associated disorders 22
Pharmacy top 2%
Clinical Biochemistry top 2%
Epidemiology
- Chronic Disease Management Strategies 13
Surgery
- Pancreatic function and diabetes 11

Co-authors: Sarah H. Wild Robert S. Lindsay Naveed Sattar Helen M. Colhoun Graham Leese Sam Philip John R. Petrie Andrew D. Morris
Cited by: Endocrinology, Diabetes and Metabolism Nephrology Genetics
Journals: Diabetologia (21 papers)Diabetic Medicine (15 papers)Diabetes Care (9 papers)
Partner nations: United Kingdom United States Ireland

In The Last Decade

John McKnight

130 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by John McKnight

Since Specialization

Citations

This map shows the geographic impact of John McKnight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McKnight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McKnight more than expected).

Fields of papers citing papers by John McKnight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John McKnight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McKnight. The network helps show where John McKnight may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John McKnight, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John McKnight Line = papers co-authored together John McKnight links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report American Journal of Case Reports ·Hafiz Muhammad Asif Javed,Arfa Ahmad,Abdul Rehman,Michael Wagner,John McKnight	2025	0
2	Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study American Journal of Kidney Diseases ·Belén Crosignani,Edouard L. Fu,Stuart J. McGurnaghan,Bryan R. Conway,Neeraj Dhaun,G.S. Vartanyan,Ewan R. Pearson,Patrick B. Mark,John R. Petrie,Helen M. Colhoun,Samira Bell,Rory J. McCrimmon,Catherine Armstrong,Alistair Emslie‐Smith,Robert S. Lindsay,Sandra MacRury,John McKnight,Donald Pearson,Brian McKinstry	2024	2
3	Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland BMJ Open ·Stuart J. McGurnaghan,Luke A. K. Blackbourn,Thomas M. Caparrotta,Joseph Mellor,Anna Barnett,J.I. Rotter,Naveed Sattar,John McKnight,John R. Petrie,Sam Philip,Robert S. Lindsay,Juozas Dûda,David McAllister,Graham Leese,Ewan R. Pearson,Sarah H. Wild,Paul McKeigue,Helen M. Colhoun	2022	15
4	The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes Diabetologia ·Andreas Höhn,Anita Jeyam,Thomas M. Caparrotta,Stuart J. McGurnaghan,Joseph O’Reilly,Luke A. K. Blackbourn,Rory J. McCrimmon,Graham Leese,John McKnight,Brian Kennon,Robert S. Lindsay,Naveed Sattar,Sarah H. Wild,Paul McKeigue,Helen M. Colhoun	2021	5
5	Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study Diabetes Care ·Joseph O’Reilly,Anita Jeyam,Thomas M. Caparrotta,Joseph Mellor,Andreas Höhn,Paul McKeigue,Nikki Alaine P Panaliganp,Luke A. K. Blackbourn,Rory J. McCrimmon,Sarah H. Wild,John R. Petrie,John McKnight,Brian Kennon,John Chalmers,G Cassandras Christos,Graham Leese,Robert S. Lindsay,Naveed Sattar,Fraser W. Gibb,Helen M. Colhoun	2021	16
6	Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study Diabetologia ·Anita Jeyam,Fraser W. Gibb,John McKnight,Joseph O’Reilly,Thomas M. Caparrotta,Andreas Höhn,Stuart J. McGurnaghan,Luke A. K. Blackbourn,Sara Hatam,Brian Kennon,Rory J. McCrimmon,Graham Leese,Sam Philip,Naveed Sattar,Paul McKeigue,Helen M. Colhoun	2021	19
7	Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium–Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland Diabetes Care ·Thomas M. Caparrotta,Luke A. K. Blackbourn,Stuart J. McGurnaghan,John Chalmers,Robert S. Lindsay,Rory J. McCrimmon,John McKnight,Sarah H. Wild,John R. Petrie,Sam Philip,Paul McKeigue,David J. Webb,Naveed Sattar,Helen M. Colhoun	2020	14
8	Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes BMC Medicine ·Paul McKeigue,Athina Spiliopoulou,Stuart J. McGurnaghan,Marco Colombo,Luke A. K. Blackbourn,Timothy J. McDonald,Dori Davari,Stephen S. Rich,(unknown),John McKnight,Mark W. J. Strachan,Alan W. Patrick,John Chalmers,Robert S. Lindsay,John R. Petrie,Thekkepat C. Sandeep,Andrew Collier,Sandra MacRury,Helen M. Colhoun	2019	51
9	The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study Diabetologia ·Stuart J. McGurnaghan,Liam Brierley,Thomas M. Caparrotta,Paul McKeigue,Luke A. K. Blackbourn,Sarah H. Wild,Graham Leese,Rory J. McCrimmon,John McKnight,Ewan R. Pearson,John R. Petrie,Naveed Sattar,Helen M. Colhoun	2019	30
10	Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes Diabetologia ·E Morenzoni,Roland H. Stimson,Nicola N. Zammitt,Stuart A. Ritchie,John McKnight,Anna R. Dover,Fraser W. Gibb	2019	126
11	Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register Diabetes Care ·Stephanie H. Read,Merel van Diepen,Helen M. Colhoun,Nynke Halbesma,Robert S. Lindsay,John McKnight,David McAllister,Ewan R. Pearson,John R. Petrie,Sam Philip,Naveed Sattar,Mark Woodward,Sarah H. Wild	2018	41
12	Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission Diabetes Care ·Sarah H. Wild,Jeremy Walker,Joanne R Morling,David McAllister,Helen M. Colhoun,Bassam Farran,Stuart J. McGurnaghan,Rory J. McCrimmon,Stephanie H. Read,Naveed Sattar,Christopher D. Byrne,Robert S. Lindsay,Graham Leese,John McKnight,John R. Petrie,John Chalmers,Colin Fischbacher,Scott Cunningham,Olívia Wu,Sam Philip	2017	98
13	Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study PLoS Medicine ·David McAllister,Katherine A. Hughes,Nazir Lone,Nicholas L. Mills,Naveed Sattar,John McKnight,Sarah H. Wild	2014	42
14	Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes BMJ Open ·Anne Douglas,Raj Bhopal,WENDY SALKIN,WENDY SALKIN,John Forbes,Jason M. R. Gill,John McKnight,Gordon Murray,Naveed Sattar,Anu Sharma,Sunita Wallia,Sarah H. Wild,Aziz Sheikh	2013	12
15	Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial The Lancet Diabetes & Endocrinology ·Raj Bhopal,Anne Douglas,Sunita Wallia,John Forbes,Michael E. J. Lean,Jason M. R. Gill,John McKnight,Naveed Sattar,Aziz Sheikh,Sarah H. Wild,(unknown),Anu Sharma,WENDY SALKIN,Joel Smith,Isabella Butcher,Gordon Murray	2013	114
16	Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia ·Jennifer Logue,Jeremy Walker,Helen M. Colhoun,Graham Leese,Robert S. Lindsay,John McKnight,Andrew D. Morris,D. Pearson,John R. Petrie,Sam Philip,Sarah H. Wild,Naveed Sattar	2011	226
17	Reference values for nerve function assessments among a study population in northern India - II: thermal sensation thresholds Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) ·John McKnight,Peter Nicholls,Loretta Das,K V Desikan,Diana N. J. Lockwood,Einar Wilder‐Smith,Wim H. van Brakel	2010	2
18	Management of diabetes in pregnancy Karen Adamson,John McKnight	2008	2
19	Severe acidosis in patients taking metformin—rapid reversal and survival despite high APACHE score Diabetic Medicine ·Moffat Nyirenda,Thekkepat C. Sandeep,I. S. Grant,Geraint Price,John McKnight	2006	33
20	Basal and Stimulated Plasma Atrial Natriuretic Factor in Patients With Type 1 Diabetes With and Without Nephropathy Diabetic Medicine ·John McKnight,X-X Hu,B. Sheridan,P. M. Bell,A. B. Atkinson	1991	4

About John McKnight

John McKnight is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Pharmacy, Genetics and Cardiology and Cardiovascular Medicine, having authored 137 papers that have together received 4.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (39 papers), Diabetes Treatment and Management (29 papers), Diabetes and associated disorders (22 papers), Diabetes Management and Education (16 papers), Chronic Disease Management Strategies (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Pancreatic function and diabetes (11 papers) and Pituitary Gland Disorders and Treatments (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.4k citations), Nephrology (360 citations), Genetics (912 citations), Pharmacy (144 citations) and Clinical Biochemistry (168 citations). John McKnight has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Sarah H. Wild, Robert S. Lindsay, Naveed Sattar, Helen M. Colhoun, Graham Leese, Sam Philip, John R. Petrie, Andrew D. Morris, Helen C. Looker and Shona Livingstone. Their work appears in journals such as Diabetologia, Diabetic Medicine, Diabetes Care, Clinical Endocrinology and European Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact